MAM
JAZZ icon

Meeder Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Meeder Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34K Sell
18
-24
-57% -$5.26K ﹤0.01% 863
2026
Q1 		$7.94K Buy
42
+11
+35% +$1.92K ﹤0.01% 746
2025
Q4 		$5.27K Sell
31
-1
-3% -$153 ﹤0.01% 789
2025
Q3 		$4.22K Buy
32
+2
+7% +$240 ﹤0.01% 703
2025
Q2 		$3.18K Buy
+30
New +$3.26K ﹤0.01% 770
2022
Q4 		– Sell
-125
Closed -$17K – 1401
2022
Q3 		$17K Buy
125
+76
+155% +$11.6K ﹤0.01% 1154
2022
Q2 		$8K Sell
49
-204
-81% -$31.4K ﹤0.01% 1455
2022
Q1 		$39K Sell
253
-22
-8% -$3.19K ﹤0.01% 1048
2021
Q4 		$35K Sell
275
-3
-1% -$394 ﹤0.01% 552
2021
Q3 		$36K Sell
278
-968
-78% -$146K ﹤0.01% 1198
2021
Q2 		$221K Sell
1,246
-327
-21% -$56.6K 0.01% 702
2021
Q1 		$259K Buy
1,573
+1,529
+3,475% +$252K 0.01% 673
2020
Q4 		$7K Sell
44
-164
-79% -$24.4K ﹤0.01% 1104
2020
Q3 		$29K Sell
208
-1,878
-90% -$233K ﹤0.01% 1070
2020
Q2 		$230K Sell
2,086
-453
-18% -$50.1K 0.02% 565
2020
Q1 		$253K Buy
2,539
+32
+1% +$4.14K 0.02% 506
2019
Q4 		$375K Buy
2,507
+34
+1% +$4.63K 0.02% 448
2019
Q3 		$317K Sell
2,473
-30
-1% -$4.02K 0.02% 495
2019
Q2 		$358K Sell
2,503
-94
-4% -$12.6K 0.03% 464
2019
Q1 		$372K Hold
2,597
– – 0.03% 426
2018
Q4 		$321K Sell
2,597
-334
-11% -$49.5K 0.03% 403
2018
Q3 		$494K Buy
+2,931
New +$504K 0.04% 357

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Meeder Asset Management's JAZZ Position: Q2 2026 in Review

Meeder Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 57% in Q2 2026, selling an estimated $5.26K and leaving 18 shares worth $4.34K. The position accounts for ﹤0.01% of the portfolio, ranked #863.

Meeder Asset Management first reported a position in JAZZ in Q3 2018 and has held it in 22 quarters since. The position peaked at $494K in Q3 2018. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Meeder Asset Management held 18 shares of Jazz Pharmaceuticals worth $4.34K as of Q2 2026.
  • Meeder Asset Management sold 24 Jazz Pharmaceuticals shares in Q2 2026, an estimated $5.26K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Meeder Asset Management's portfolio in Q2 2026, its #863 holding.
  • Meeder Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2018 and has held it in 22 quarters since.
  • Meeder Asset Management's Jazz Pharmaceuticals position peaked at $494K in Q3 2018.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.